title: The chromosomal protein HMGN2 mediates the LPS-induced expression of β-defensins in mice.
abstract: Human β-defensin-2 (HBD-2), an antimicrobial peptide produced by epithelial cells, plays an important role in the body's innate and adaptive immunity. High-mobility group N2 (HMGN2), a member of the HMG superfamily, binds to chromatin to modulate gene transcription. Previously, we have shown that HMGN2 acts as a positive modulator of the signal transduction cascade in the process of inducible human β-defensin expression. In our current study, we found that down-regulation of HMGN2 reduces the expression level of murine β-defensin-3 and -4 (mBD-3 and mBD-4), but not mBD-1 upon LPS stimulation in various tissues of pregnant ICR mice, as well as in embryonic and neonatal lungs and livers at different developmental time points. In the control group, murine HMGN2 expression decreased, while mBD-1 and mBD-4 expression increased slightly during development. In the LPS-treated groups, murine HMGN2 and mBD-1 expression did not change significantly, whereas mBD-3 and mBD-4 expression significantly increased in maternal, embryonic, and neonatal tissues, especially the mBD-3 expression. HMGN2 shRNA interference led to decreased mBD-3 and mBD-4 expression, while mBD-1 expression did not significantly change. These results demonstrate that HMGN2 is a component of the LPS-induced mouse β-defensin response.
authors: Research Unit of Infection and Immunity, West China School of Preclinical & Forensic Medicine, Chengdu, Sichuan 610041, China.
authors: Lu-Xia
authors: LX
authors: Deng
authors: Gui-Xia
authors: GX
authors: Wu
authors: Yue
authors: Y
authors: Cao
authors: Bo
authors: B
authors: Fan
authors: Xiang
authors: X
authors: Gao
authors: Xiao-Hai
authors: XH
authors: Tang
authors: Ning
authors: N
authors: Huang
references: J Allergy Clin Immunol. 1999 Dec;104(6):1131-8
references: 10588992
references: Mol Cell Biol. 2006 Jan;26(2):592-604
references: 16382150
references: FEBS J. 2005 Nov;272(22):5853-63
references: 16279949
references: J Leukoc Biol. 2005 Nov;78(5):1136-41
references: 16204630
references: J Biol Chem. 2000 Oct 27;275(43):33314-20
references: 10922379
references: Infect Immun. 1999 Jul;67(7):3542-7
references: 10377137
references: Annu Rev Physiol. 2002;64:709-48
references: 11826286
references: FEMS Immunol Med Microbiol. 2007 Oct;51(1):171-84
references: 17645739
references: Shock. 2006 Oct;26(4):365-71
references: 16980883
references: EMBO J. 2005 Sep 7;24(17):3038-48
references: 16096646
references: Mech Dev. 2003 Oct;120(10):1177-92
references: 14568106
references: J Immunol. 2003 Apr 15;170(8):4226-36
references: 12682256
references: Mol Cell Biol. 1999 Aug;19(8):5237-46
references: 10409715
references: Pediatrics. 2000 May;105(5):1013-9
references: 10790456
references: Shock. 2002 Nov;18(5):461-4
references: 12412627
references: J Neuroimmunol. 2007 Oct;190(1-2):61-71
references: 17804085
references: J Neuroimmunol. 2007 Sep;189(1-2):95-101
references: 17706793
references: Mol Cell Biol. 1995 Dec;15(12):6663-9
references: 8524231
references: Infect Immun. 2004 May;72(5):2772-9
references: 15102787
references: FEBS Lett. 1997 Aug 11;413(1):45-9
references: 9287114
references: Mamm Genome. 1998 Jun;9(6):453-7
references: 9585433
references: J Biol Chem. 2000 Sep 22;275(38):29731-6
references: 10882713
references: Ann Rheum Dis. 2003 Nov;62 Suppl 2:ii17-21
references: 14532141
references: J Immunol. 2003 Jan 1;170(1):575-80
references: 12496445
references: Hum Reprod. 2009 Jan;24(1):211-8
references: 18786935
references: Trends Biochem Sci. 2001 Jul;26(7):431-7
references: 11440855
references: Infect Immun. 1998 Mar;66(3):1225-32
references: 9488417
references: Nucleic Acids Res. 2008 Feb;36(2):462-76
references: 18045789
references: Virology. 2008 Oct 10;380(1):136-43
references: 18752820
references: Cell. 1997 Feb 21;88(4):553-60
references: 9038346
references: Mol Cell Biol. 1993 Jun;13(6):3301-10
references: 8497253
references: Thromb Haemost. 2009 Aug;102(2):352-9
references: 19652887